The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis
Abstract
Objective: To explore the antiarthritic potential of a novel synthetic cannabinoid acid, Hebrew University–320 (HU‐320), in the DBA/1 mouse model of arthritis, and to investigate in vitro antiinflammatory and immunosuppressive effects of HU‐320 on macrophages and lymphocytes. Methods: DBA/1 mice were immunized with bovine type II collagen (CII) to induce arthritis and then injected intraperitoneally daily with HU‐320. The effects of treatment on arthritic changes in hind feet were assessed clinically and histologically, and draining lymph node responses to CII were assayed. Murine splenic and human blood lymphocytes were cultured to study the effect of HU‐320 on polyclonal mitogenic stimulation. Macrophage cultures were set up to evaluate in vitro effects of HU‐320 on production of tumor necrosis factor α (TNFα) and reactive oxygen intermediates (ROIs). The effect of HU‐320 administration on lipopolysaccharide‐induced serum TNF levels was assayed using C57BL/6 mice. Bioactive TNF production was measured using BALB/c clone 7 target cells. Evaluation of HU‐320 psychoactivity was performed using established laboratory tests on Sabra mice. Results: Systemic daily administration of 1 and 2 mg/kg HU‐320 ameliorated established CII‐induced arthritis. Hind foot joints of treated mice were protected from pathologic damage. CII‐specific and polyclonal responses of murine and human lymphocytes were down‐modulated. HU‐320 inhibited production of TNF from mouse macrophages and of ROIs from RAW 264.7 cells and suppressed the rise in serum TNF level following endotoxin challenge. HU‐320 administration yielded no adverse psychotropic effects in mice. Conclusion: Our studies show that the novel synthetic cannabinoid acid HU‐320 has strong antiinflammatory and immunosuppressive properties while demonstrating no psychoactive effects. The profound suppressive effects on cellular immune responses and on the production of proinflammatory mediators all indicate its usefulness as a novel nonpsychoactive, synthetic antiinflammatory product.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Administration of CBD, or its synthetic analogs, attenuates clinical signs of arthritis and joint damage, while having an immunosuppressant effect in CIA (Haj et al, 2015;Malfait et al, 2000;Sumariwalla et al, 2004).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Sumariwalla et al, 2004
In the citing paper
“Administration of CBD, or its synthetic analogs, attenuates clinical signs of arthritis and joint damage, while having an immunosuppressant effect in CIA (Haj et al, 2015;Malfait et al, 2000;Sumariwalla et al, 2004).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Sumariwalla et al, 2004
Citations
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationMoreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R., Weaver, A. L., Ettlinger, R. E., Cohen, S. B., Koopman, W. J., Mohler, K. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,620
Etanercept Therapy in Rheumatoid Arthritis
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,403
Lee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,328
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Self-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,252
Self-citationUse of MTT colorimetric assay to measure cell activation
Gerlier, D., & Thomasset, N. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90215-2 · Cited by 1,203
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P. J., Katsikis, P. D., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Self-citationImmunisation against heterologous type II collagen induces arthritis in mice
COURTENAY, J. S., Dallman, M. J., Dayan, A. D., Martin, A. J., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 1,006
Self-citationAnti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 991
Self-citationFunctional macrophage cell lines transformed by abelson leukemia virus
Raschke, W. C., Baird, S. M., Ralph, P., & Nakoinz, I. (1978) · Cell · doi:10.1016/0092-8674(78)90101-0 · Cited by 906
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Self-citationAction of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 581
Self-citationCannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530
Self-citationMechoulam, R. (1970) · Science · doi:10.1126/science.168.3936.1159 · Cited by 501
Self-citationMechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486
Self-citationPharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 448
Self-citationStructural studies on cartilage collagen employing limited cleavage and solubilization with pepsin
Miller, E. J. (1972) · Biochemistry · doi:10.1021/bi00776a005 · Cited by 416
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
Martin, B. R., Compton, D. M., Thomas, B. F., Prescott, W. R., Little, P., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., & Ward Susan, J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90349-7 · Cited by 410
Self-citationShohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 332
Self-citationMauri, C., Williams, R. O., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260716 · Cited by 309
Self-citationBiphasic Effects of Anandamide
Sulcova, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00422-x · Cited by 265
Antipsychotic effect of cannabidiol.
Zuardi, A. W., Morais, S. L., Guimarães, F. S., & Mechoulam, R. (1995) · PubMed · Cited by 264
Self-citationRothstein, J. L., & Schreiber, H. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.607 · Cited by 259
Collagen arthritis as a relevant model for rheumatoid arthritis. evidence pro and con
Trentham, D. E. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250801 · Cited by 254
Cannabinoid receptors and immunity
Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235
Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., & Lesslauer, W. (1992) · PubMed Central · Cited by 232
Cannabinoids and brain injury: therapeutic implications
Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229
Self-citationCompton, D. M., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 216
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M. H., Vogel, Z., Barg, J., Bayewitch, M. L., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 200
Self-citationThe ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice
Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06900.x · Cited by 189
Sebbag, M., Parry, S. L., Brennan, F. M., & Feldmann, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270308 · Cited by 178
Self-citationFrom gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis
Mechoulam, R., & Ben‐Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 145
Self-citationMalfait, A., Butler, D., Presky, D. H., Maini, R. N., Brennan, F. M., & Feldmann, M. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00485.x · Cited by 142
Self-citationAnalgesic and antiinflammatory activity of constituents ofCannabis sativa L.
Formukong, E. A., EVANS, A. T., & Evans, F. J. (1988) · Inflammation · doi:10.1007/bf00915771 · Cited by 130
Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90160-9 · Cited by 111
BURSTEIN, S. H., Audette, C. A., Breuer, A., Devane, W. A., Colodner, S., Doyle, S. A., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00095a007 · Cited by 99
Self-citationZurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1 · Cited by 96
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
Guimarães, F. S., Aguiar, J. C. D., Mechoulam, R., & Breuer, A. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90027-2 · Cited by 89
Self-citationTetrahydrocannabinol inhibition of macrophage nitric oxide production
Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77
T-cell-dependent pathways in rheumatoid arthritis
Panayi, G. S. (1997) · Current Opinion in Rheumatology · doi:10.1097/00002281-199705000-00010 · Cited by 77
Brenner, T., Yamin, A., Abramsky, O., & Gallily, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91468-8 · Cited by 63
Self-citationAntioxidants Attenuate Acute Toxicity of Tumor Necrosis Factor-alpha Induced by Brain Injury in Rat
Trembovler, V., Beit‐Yannai, E., Younis, F. M., Gallily, R., Horowitz, M., & Shohami, E. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313640 · Cited by 61
Self-citationDajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M., Dayton, M. T., & Mir, G. (1999) · PubMed · Cited by 57
Rodent models of arthritis: relevance for human disease
Williams, R. O. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00785.x · Cited by 55
Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages
Catterall, J. R., Black, C. M., Leventhal, J. P., Rizk, N. W., Wachtel, J. S., & Remington, J. S. (1987) · Infection and Immunity · doi:10.1128/iai.55.7.1635-1640.1987 · Cited by 45
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
Fride, E., & Shohami, E. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00001 · Cited by 44
Self-citationAjulemic Acid (CT3) A Potent Analog of the Acid Metabolites of THC
BURSTEIN, S. H. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399473 · Cited by 40
Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages
Avron, A., & Gallily, R. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.2.264 · Cited by 35
Self-citationLooking Back at Cannabis Research
Mechoulam, R. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399509 · Cited by 33
Self-citationCarpenter, E. A., Fray, L. M., & Gormley, E. P. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00760.x · Cited by 26
Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
Williams, R. O., Malfait, A., Butler, D., Walmsley, M. J., Feldmann, M., & Maini, R. N. (1999) · PubMed · Cited by 9
Self-citationMitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Self-citation
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 710
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 632
Metadata
- Authors
- Sumariwalla, P. F., Gallily, R., Tchilibon, S., Fride, E., Mechoulam, R., & Feldmann, M.
- Affiliations
- Imperial College London (GB)
- Hebrew University of Jerusalem (IL)
- Ariel University (IL)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 50
- Issue
- 3
- Pages
- 985-998
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2056056547
- Cited by
- 134
- References
- 57
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 2 · 2012: 3
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- collagen-induced arthritis, anti-inflammatory activity, immunosuppression, TNF-α, reactive oxygen species, macrophages, lymphocytes, cell-mediated immunity, DBA/1 mice
- MeSH terms
- Animals, Anti-Inflammatory Agents, Arthritis, Experimental, Cannabidiol, Cattle, Cells, Cultured, Central Nervous System, Cyclohexanecarboxylic Acids, Female, Humans, Immunity, Cellular, Immunosuppressive Agents, Joints, Lipopolysaccharides, Lymphocytes, Macrophages, Mice, Inbred BALB C, Mice, Inbred C57BL, Mitosis, Severity of Illness Index, Tumor Necrosis Factor-alpha, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
